Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia

This publication has 27 references indexed in Scilit:

• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
  Journal of Clinical Investigation, 2003
• Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome
  The American Journal of Pathology, 2002
• Pregnancy-related mortality from preeclampsia and eclampsia
  Obstetrics & Gynecology, 2001
• Pathogenesis and genetics of pre-eclampsia
  The Lancet, 2001
• Increased circulating lipid peroxides in severe preeclampsia activate NF‐κΒ and upregulate ICAM‐1 in vascular endothelial cells
  The FASEB Journal, 2000
• Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and pre‐eclamptic pregnancy
  BJOG: An International Journal of Obstetrics and Gynaecology, 2000
• Regulation of Placental Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PlGF) and Soluble Flt-1 by Oxygen— A Review
  Placenta, 2000
• The nitric oxide pathway in pre-eclampsia: pathophysiological implications
  Human Reproduction Update, 1998
• Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia
  American Journal of Obstetrics and Gynecology, 1990
• Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells
  American Journal of Obstetrics and Gynecology, 1988